Gadodiamide has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of teratogenicity. There are no controlled data in human pregnancy. Gadodiamide is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.

See references

There are no data on the excretion of gadodiamide into human milk. The effects in the nursing infant are unknown. The manufacturer recommends that caution be used when administering gadodiamide to nursing women.

See references